EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

From Molecular to Radionuclide and Pharmacological Aspects in Transthyretin Cardiac Amyloidosis

Silviu Marcel Stanciu, Ruxandra Jurcut, Ruxandra Dragoi Galrinho, Constantin Stefani, Daniela Miricescu, Ioana Ruxandra Rusu, Georgiana Sabina Prisacariu iD, Raluca Mititelu iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms26010146 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Silviu Marcel Stanciu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Gastroenterology, Carol Davila University of Medicine and Pharmacy, Central Military Emergency University Hospita…. Hauptthemen laut MEDLINE: Amyloid Neuropathies, Familial, Cardiomyopathies. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyloidosis is a rare pathology characterized by protein deposits in various organs and tissues. Cardiac amyloidosis (CA) can be caused by various protein deposits, but transthyretin amyloidosis (ATTR) and immunoglobulin light chain (AL) are the most frequent pathologies. Protein misfolding can be induced by several factors such as oxidative stress, genetic mutations, aging, chronic inflammation, and neoplastic disorders. In ATTR cardiomyopathy (ATTR-CM), the amyloid fibrils can be found in the myocardium interstitial space and are associated with arrhythmias and heart failure. In pathological situations, the transthyretin (TTR) configuration is destroyed by proteolytic action, leading to monomers that further misfold and aggregate to form the amyloid fibrils. 99mTc-Pyrophosphate (99m-Tc-PYP), 99mTc 3,3-diphosphono-1,2-propanodicarboxylic acid (99m-Tc-DPD) and 99m-Tc hydroxy-methylene-Dyphosphonate (99m-Tc-HMDP) are used to detect myocardium amyloid deposits due to their ability to detect calcium ions that are present in the amyloid fibrils through dystrophic calcification. ATTR-CM therapy acts on different stages of the amyloidogenic process, including liver TTR synthesis, TTR tetramer destabilization, and misfolding of the monomers. The main aim of this narrative review is to present ATTR-CM, starting with molecular changes regarding the protein misfolding process and radionuclide aspects and finishing with pharmacological approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid Neuropathies, FamilialCardiomyopathiesHumansPrealbuminAnimalsAmyloidMyocardiumRadiopharmaceuticals

Stichwörter der Autor:innen

TTR depletersTTR knockdownTTR stabilizerscardiac amyloidosisprotein misfoldingradionuclide imagingtransthyretin cardiac amyloidosis

Substanzen

PrealbuminAmyloidRadiopharmaceuticals

Autor:innen und Institutionen

  • Department of Internal Medicine and Gastroenterology, Carol Davila University of Medicine and Pharmacy, Central Military Emergency University Hospital, 010825 Bucharest, Romania.
  • Department of Cardiology, Carol Davila University of Medicine and Pharmacy, Institute of Cardiovascular Diseases "Prof CC Iliescu", 022322 Bucharest, Romania.
  • Department of Cardiology and Cardiovascular Surgery, University and Emergency Hospital, 050098 Bucharest, Romania.
  • Department I of Family Medicine and Clinical Base, "Dr. Carol Davila" Central Military Emergency University Hospital, 010825 Bucharest, Romania.
  • Discipline of Biochemistry, Faculty of Dentistry, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
  • Discipline of Anatomy, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.

ORCID-Profile: Georgiana Sabina Prisacariu, Raluca Mititelu

Förderung

  • Pfizer

Zitieren

APA

Stanciu, S. M., Jurcut, R., Dragoi Galrinho, R., Stefani, C., Miricescu, D., Rusu, I. R., Prisacariu, G. S., & Mititelu, R. (2024). From Molecular to Radionuclide and Pharmacological Aspects in Transthyretin Cardiac Amyloidosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26010146

Vancouver

Stanciu SM, Jurcut R, Dragoi Galrinho R, Stefani C, Miricescu D, Rusu IR, et al. From Molecular to Radionuclide and Pharmacological Aspects in Transthyretin Cardiac Amyloidosis. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms26010146

BibTeX
@article{Stanciu2024,
  author = {Stanciu, Silviu Marcel and Jurcut, Ruxandra and Dragoi Galrinho, Ruxandra and Stefani, Constantin and Miricescu, Daniela and Rusu, Ioana Ruxandra and Prisacariu, Georgiana Sabina and Mititelu, Raluca},
  title = {From Molecular to Radionuclide and Pharmacological Aspects in Transthyretin Cardiac Amyloidosis},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms26010146}
}
Kostenlos starten →